AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$16.20−1.10 (-6.36%)
Close on Nov 12, 2026Market cap $501.02MP/E –Yield –
AVITA Medical operating margin
Operating margin is operating income as a percentage of revenue.
AVITA Medical's operating margin for the twelve months ending Sep 30, 2026 was -33.9%. For fiscal 2025 it was -59.4%, against -88.1% the year before. The highest annual figure on record is -59.4% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -59.4% | +28.7 |
| FY2024 | Dec 31, 2024 | -88.1% | −3.0 |
| FY2023 | Dec 31, 2023 | -85.1% | +5.7 |
| FY2021 | Jun 30, 2021 | -90.8% | +208.4 |
| FY2020 | Jun 30, 2020 | -299.2% | +167.1 |
| FY2019 | Jun 30, 2019 | -466.4% | +1023.5 |
| FY2018 | Jun 30, 2018 | -1489.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -10.1% | +43.6 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -31.6% | +28.9 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -45.7% | +18.2 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -59.1% | −5.0 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -53.6% | +17.0 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -60.5% | +42.3 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -63.9% | +91.1 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -54.1% | +32.4 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -70.6% | −2.4 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -102.8% | −7.8 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -155.0% | −61.0 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -86.5% | −40.8 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -68.2% | +0.2 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -95.0% | +15.3 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -93.9% | +107.9 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -45.7% | +290.3 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -68.4% | +329.0 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -110.3% | +214.7 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -201.9% | −89.3 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -335.9% | −30.8 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -397.4% | −6.8 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -325.0% | +280.8 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -112.6% | +1767.7 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -305.1% | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -390.6% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -605.8% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -1880.3% | – |
See a number that looks wrong?